• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床医生主观性对英国公共医疗患者群体中干眼症患病率评估的影响

Impact of Clinician Subjectivity on the Assessment of Dry Eye Disease Prevalence in a UK Public Health Care Patient Population.

作者信息

Sullivan Benjamin D, Smith Guy T, Gupta Arun, Harman Francesca, Ansari Ejaz

机构信息

Trukera Medical, Southlake, TX, USA.

The Great Western Hospital NHS Trust, Swindon, UK.

出版信息

Clin Ophthalmol. 2024 Mar 8;18:743-753. doi: 10.2147/OPTH.S452149. eCollection 2024.

DOI:10.2147/OPTH.S452149
PMID:38476359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10929644/
Abstract

PURPOSE

To understand the impact of subjectivity on diagnosis rates of dry eye disease (DED) in an unbiased population.

PATIENTS AND METHODS

A multicenter study enrolled 818 subjects with complete report forms (465 females, 67.1 ± 16.7 years, 353 males, 65.0 ± 15.9 years). Subjects were evaluated for staining, TBUT, tear osmolarity, meibomian gland disease, and OSDI.

RESULTS

Physicians diagnosed 48.7% of subjects as having DED, ranging from 42.9% to 62.3% between sites. Positivity rates for staining (≥ grade 1) ranged from 41.3% to 84.1% (mean = 0.8 ± 0.9 grade), TBUT (<10s) ranged from 39.1% to 61.6% (mean = 10.4 ± 6.6 seconds), osmolarity (>308 mOsm/L) ranged from 63.7% to 72.4% (mean = 319.7 ± 20.8), MGD grading ranged from 28.9% to 51.3% (mean = 0.5 ± 0.7), and symptoms measured by OSDI ranged from 57.6% to 71.0% (mean = 23.5 ± 20.5) between sites. Tear osmolarity was the most consistent between sites (max/min positivity = 114%), followed by OSDI (123%), TBUT (158%), MGD (178%), and staining (204%). DED markers were uncorrelated (average = 0.05 ± 0.07). A substantial number of subjects (N = 110) exhibited positive symptoms (OSDI = 32.4 ± 15.7) and hyperosmolarity (338.1 ± 20.1 mOsm/L) but no other obvious signs of DED (MGD grade = 0.2 ± 0.4, TBUT = 13.5 ± 7.0 seconds, staining grade = 0.4 ± 0.5).

CONCLUSION

Subjective signs of DED varied considerably, whereas objective measurements of OSDI and osmolarity were the most consistent between sites. A large proportion of subjects exhibited high symptoms and hyperosmolarity but no other obvious signs of dry eye disease, most of whom were undiagnosed by clinical assessment without access to the osmolarity measurement.

摘要

目的

了解主观性对无偏倚人群中干眼症(DED)诊断率的影响。

患者与方法

一项多中心研究纳入了818名填写了完整报告表的受试者(465名女性,年龄67.1±16.7岁;353名男性,年龄65.0±15.9岁)。对受试者进行了染色、泪膜破裂时间(TBUT)、泪液渗透压、睑板腺疾病及眼表疾病指数(OSDI)评估。

结果

医生诊断48.7%的受试者患有DED,各研究点的诊断率在42.9%至62.3%之间。染色阳性率(≥1级)在41.3%至84.1%之间(平均等级为0.8±0.9级),TBUT(<10秒)在39.1%至61.6%之间(平均为10.4±6.6秒),渗透压(>308 mOsm/L)在63.7%至72.4%之间(平均为319.7±20.8),睑板腺疾病分级在28.9%至51.3%之间(平均为0.5±0.7),各研究点间通过OSDI测量的症状发生率在57.6%至71.0%之间(平均为23.5±20.5)。泪液渗透压在各研究点间最为一致(最大/最小阳性率=114%),其次是OSDI(123%)、TBUT(158%)、睑板腺疾病(178%)和染色(204%)。DED各项指标之间无相关性(平均为0.05±0.07)。相当数量的受试者(N=110)表现出阳性症状(OSDI=32.4±15.7)和高渗状态(338.1±20.1 mOsm/L),但无其他明显的DED体征(睑板腺疾病分级=0.2±0.4,TBUT=13.5±7.0秒,染色分级=0.4±0.5)。

结论

DED的主观体征差异很大,而OSDI和渗透压的客观测量在各研究点间最为一致。很大一部分受试者表现出高症状和高渗状态,但无其他明显的干眼症体征,其中大多数人未经临床评估且未进行渗透压测量而未被诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac43/10929644/5aa9f14788e0/OPTH-18-743-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac43/10929644/bb37fb1c144b/OPTH-18-743-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac43/10929644/5aa9f14788e0/OPTH-18-743-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac43/10929644/bb37fb1c144b/OPTH-18-743-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac43/10929644/5aa9f14788e0/OPTH-18-743-g0002.jpg

相似文献

1
Impact of Clinician Subjectivity on the Assessment of Dry Eye Disease Prevalence in a UK Public Health Care Patient Population.临床医生主观性对英国公共医疗患者群体中干眼症患病率评估的影响
Clin Ophthalmol. 2024 Mar 8;18:743-753. doi: 10.2147/OPTH.S452149. eCollection 2024.
2
Age Associations with Dry Eye Clinical Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study.干眼症评估与管理(DREAM)研究中年龄与干眼临床体征及症状的关联
Ophthalmol Sci. 2023 Jan 12;3(2):100270. doi: 10.1016/j.xops.2023.100270. eCollection 2023 Jun.
3
Evaluation of incomplete blinking as a measurement of dry eye disease.评估不完全眨眼作为干眼症的测量指标。
Ocul Surf. 2019 Jul;17(3):440-446. doi: 10.1016/j.jtos.2019.05.007. Epub 2019 May 29.
4
Prevalence of Dry Eye Disease Among Individuals Scheduled for Cataract Surgery in a Norwegian Cataract Clinic.挪威一家白内障诊所中计划进行白内障手术的患者干眼疾病患病率。
Clin Ophthalmol. 2023 Apr 27;17:1233-1243. doi: 10.2147/OPTH.S407805. eCollection 2023.
5
Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction.强脉冲光(IPL)疗法治疗睑板腺功能障碍。
Cochrane Database Syst Rev. 2020 Mar 18;3(3):CD013559. doi: 10.1002/14651858.CD013559.
6
Association between systemic medication use and severity of dry eye signs and symptoms in the DRy eye assessment and management (DREAM) study.DRy 眼评估和管理(DREAM)研究中系统用药与干眼体征和症状严重程度的相关性。
Ocul Surf. 2024 Apr;32:112-119. doi: 10.1016/j.jtos.2024.01.009. Epub 2024 Feb 1.
7
Subjective versus objective dry eye disease in patients with moderate-severe thyroid eye disease.中重度甲状腺眼病患者的主观与客观干眼症。
Ocul Surf. 2018 Oct;16(4):458-462. doi: 10.1016/j.jtos.2018.07.003. Epub 2018 Jul 7.
8
Intereye Agreement in Dry-Eye Signs in the DREAM Study: Implications for Future Dry-Eye Trials.DREAM研究中干眼体征的双眼一致性:对未来干眼试验的启示
Cornea. 2025 Feb 1;44(2):149-156. doi: 10.1097/ICO.0000000000003605. Epub 2024 Jul 30.
9
Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction.强脉冲光与睑板腺按摩对缓解睑板腺功能障碍所致干眼疾病体征和症状疗效的前瞻性评估
Clin Ophthalmol. 2017 May 2;11:817-827. doi: 10.2147/OPTH.S130706. eCollection 2017.
10
Effect of thermal pulsation treatment on tear film parameters in dry eye disease patients.热脉动治疗对干眼患者泪膜参数的影响。
Clin Ophthalmol. 2017 May 9;11:883-886. doi: 10.2147/OPTH.S136203. eCollection 2017.

本文引用的文献

1
Association of Tear Osmolarity With Signs and Symptoms of Dry Eye Disease in the Dry Eye Assessment and Management (DREAM) Study.干眼评估和管理(DREAM)研究中泪液渗透压与干眼疾病相关体征和症状的相关性。
Invest Ophthalmol Vis Sci. 2023 Jan 3;64(1):5. doi: 10.1167/iovs.64.1.5.
2
Automated vs. human evaluation of corneal staining.自动评估与人工评估角膜染色。
Graefes Arch Clin Exp Ophthalmol. 2022 Aug;260(8):2605-2612. doi: 10.1007/s00417-022-05574-0. Epub 2022 Mar 31.
3
Dry Eye in Systemic Sclerosis Patients: Novel Methods to Monitor Disease Activity.
系统性硬化症患者的干眼症:监测疾病活动的新方法。
Diagnostics (Basel). 2020 Jun 13;10(6):404. doi: 10.3390/diagnostics10060404.
4
Ocular Clinical Signs and Diagnostic Tests Most Compatible With Keratoconjunctivitis Sicca: A Latent Class Approach.眼临床体征和诊断测试与干燥性角结膜炎最相容:潜在类别方法。
Cornea. 2020 Aug;39(8):1013-1016. doi: 10.1097/ICO.0000000000002311.
5
Utility of Tear Osmolarity Measurement in Diagnosis of Dry Eye Disease.泪液渗透压测量在干眼病诊断中的应用。
Sci Rep. 2020 Mar 26;10(1):5542. doi: 10.1038/s41598-020-62583-x.
6
Androgen Suppresses Hyperosmolarity-Induced Inflammatory Mediators in Human Corneal Epithelial Cells.雄激素抑制人角膜上皮细胞高渗诱导的炎症介质。
Cornea. 2020 Jul;39(7):886-891. doi: 10.1097/ICO.0000000000002291.
7
Multiscale reverse engineering of the human ocular surface.人体眼表面的多尺度反向工程。
Nat Med. 2019 Aug;25(8):1310-1318. doi: 10.1038/s41591-019-0531-2. Epub 2019 Aug 5.
8
Longitudinal changes in dry eye symptoms and signs following lifitegrast therapy and relationship to tear osmolarity.lifitegrast治疗后干眼症状和体征的纵向变化及其与泪液渗透压的关系。
Clin Ophthalmol. 2019 Mar 28;13:571-579. doi: 10.2147/OPTH.S196593. eCollection 2019.
9
Change of tear osmolarity after refractive surgery.屈光手术后泪液渗透压的变化。
Cesk Slov Oftalmol. 2018 Spring;74(1):18-22.
10
Short Tear Film Breakup Time-Type Dry Eye.短瞬泪膜破裂时间型干眼症。
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(14):DES64-DES70. doi: 10.1167/iovs.17-23746.